Your cart is empty.
Männedorf, Switzerland, July 28, 2010 – Tecan and PhyNexus have developed standard processes for automating protein purification using PhyTip® columns integrated onto a Freedom EVO® liquid handling platform. The Freedom EVO is equipped with a liquid handling arm and a MultiChannel Arm(tm), and controlled using specially adapted scripts of standard Freedom EVOware® operating software. Although primarily used for protein purification, the disposable PhyTip columns can be supplied packed with various types of resin, making their application range extremely broad. The majority of PhyTip columns do not require additional hardware, the only exception being gel filtration columns, which use a specific PhyNexus rack and are transported on the Freedom EVO platform by a robotic manipulator arm.
Kevin Moore, Tecan's Director of Market and Application Management for BioPharma, said: “We are very pleased to be working with PhyNexus to bring an automation solution to customers in the fast growing area of protein purification. This will increase Tecan's offering to the bioprocessing community.” Douglas Gjerde, PhyNexus CEO, added: ”We are very excited to partner with Tecan, and have been particularly impressed with the professionalism, enthusiasm, and technical competence of their team.”
To find out more on Tecan's Freedom EVO/PhyTip column integration, visit http://www.tecan.com/phynexus. To find out more on PhyNexus PhyTip columns, visit PhyNexus, Inc.
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).
For more information about Tecan, please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
For more information about PhyNexus, please contact:
Inc. 3670 Charter Park Drive
Suite A San Jose, CA 95136
Tel +1 408 267 7214
Fax +1 408 267 7346